CHRISTINA ARMIJO: Open Payments
NPI 1144684317 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$825 in 38 payments from 10 companies in 2025. Trend: 2023 $688 · 2024 $295 · 2025 $825
Food & beverage: $825
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $185 |
| Amgen Inc. | 6 | $147 |
| UCB, Inc. | 4 | $115 |
| E.R. Squibb & Sons, L.L.C. | 4 | $91 |
| AstraZeneca Pharmaceuticals LP | 4 | $83 |
| Genentech USA, Inc. | 3 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Organon LLC | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Alexion Pharmaceuticals, Inc. | 1 | $19 |
Products named: Bimzelx, RINVOQ, ORENCIA, SKYRIZI, SAPHNELO, KRYSTEXXA, OTEZLA, Gazyva.
Industry payments across TX — which companies pay providers there.
